Status:
COMPLETED
Study of Gynecological Follow-up Concerning Women With Multiple Sclerosis
Lead Sponsor:
University Hospital, Bordeaux
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Multiple Sclerosis
Eligibility:
FEMALE
18-40 years
Brief Summary
The investigators want to evaluate gynecological follow-up concerning patients with multiple sclerosis. This study will include reproductive women (from 18 to 40 years old). Patients in the study have...
Detailed Description
Multiple sclerosis is an inflammatory disease of central nervous system, with a prevalence rate in France of 1 case/1000 subjects (120 000 subjects in France). The average age at diagnosis is 30 years...
Eligibility Criteria
Inclusion
- Aged between 18 to 40 years old ;
- Diagnosis of multiple sclerosis based on McDonald Criteria 2017 ;
- Patient whose clinical data are referenced in the European Database for Multiple Sclerosis (EDMUS) clinical database (OFSEP database for collecting clinical data from patients followed in the neurology department) ;
- French-speaking, without comprehension disorders ;
- being affiliated to health insurance ;
- Willing to participate and to sign informed consent.
Exclusion
- pregnant or breastfeeding women ;
- patient concerned by articles L 1121-5 to L 1121-8 (persons deprived of their liberty by a judicial or administrative decision, minors, persons of legal age who are the object of a legal protection measure or unable to express their consent).
Key Trial Info
Start Date :
May 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 9 2023
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT05248438
Start Date
May 11 2022
End Date
May 9 2023
Last Update
June 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Bordeaux - service de neurologie
Bordeaux, France